Is there a Cytomel T3 cycle, and how is liothyronine dosed?
| Group | Label dose and stepping |
|---|---|
| Adults with hypothyroidism | Start 25 mcg once daily, raise by 25 mcg daily every 1 or 2 weeks if needed; maintenance 25 to 75 mcg once daily.1 |
| Elderly or underlying cardiac disease | Start 5 mcg once daily, raise by 5 mcg at the recommended intervals.1 |
| Children with hypothyroidism | Start 5 mcg once daily, raise by 5 mcg every 3 to 4 days until the desired response is achieved.1 |
| Thyroid suppression test | 75 to 100 mcg daily for 7 days.1 |
No label, trial or registry entry in the pack's searches describes a liothyronine cycle of on and off weeks, and the Cytomel label, whose boxed warning is headed not for treatment of obesity or for weight loss, gives a starting dosage of 25 mcg once daily for adults with hypothyroidism, increased by 25 mcg daily every 1 or 2 weeks if needed.1
What strengths and doses does the Cytomel label give?
The table is set at the top of the page
Cytomel tablets come in 5, 25 and 50 mcg, supplied in bottles of 100.1 The Liomny label gives the same starting dose and stepping as Cytomel.2
The label says to give Cytomel orally once daily, and that the dose depends on factors including age, body weight, cardiovascular status, other medical conditions (including pregnancy), other medicines, food taken with it and the condition being treated, with dosing individualized to account for them.1 For thyroid cancer it gives no fixed number and aims at a TSH range, and it says oral thyroid hormone is not recommended for myxedema coma.1 Milligram has no logged liothyronine dose or schedule that meets its reporting floor, so none is printed.
What did trials of levothyroxine plus liothyronine use?
The Cytomel label gives liothyronine once daily; in the trials below, Clyde and Phan gave it twice daily and LEVOLIO in the morning and the evening.1345 When switching, it says to stop levothyroxine and start Cytomel at a low dose.1 The injection label gives 25 mcg of liothyronine as equivalent to approximately 0.1 mg of L-thyroxine in euthyroid patients.6
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Clyde | Levothyroxine alone, or levothyroxine cut by 50 micro g/d and replaced with liothyronine 7.5 micro g twice daily.3 | 46 patients aged 24 to 65, 23 per arm3 | 4 months3 |
| Appelhof | Levothyroxine alone, or levothyroxine plus liothyronine at a 10:1 or 5:1 ratio.7 | 141 patients aged 18 to 70 with primary autoimmune hypothyroidism (48, 46 and 47 per arm) | 15 weeks to the primary outcome |
| Kaminski | Levothyroxine and liothyronine at a fixed 75/15 µg a day, against continued levothyroxine (125 or 150 μg/day) in a crossover.8 | 32 adults with primary hypothyroidism | 8 weeks each |
| LEVOLIO (Brigante) | Levothyroxine plus liothyronine in the morning and liothyronine in the evening, against levothyroxine in the morning and placebo in the evening; mean liothyronine 5.00 µg a day, levothyroxine reduced by a mean 15 µg.4 | Totally thyroidectomized subjects: 70 on combination, 71 on levothyroxine plus placebo | 6 months |
| Phan | Levothyroxine cut by 25 mcg plus liothyronine 5 mcg twice daily, against levothyroxine plus placebo.5 | Thirteen randomised after total thyroidectomy; twelve analysed (five on combination, seven on placebo) | Analysed at a three-month follow-up visit or later |
What do a consensus document and a meta-analysis say about adding liothyronine?
The 2021 consensus document by Jonklaas and colleagues says that, for future trials, because three times daily liothyronine is too onerous and a sustained-release preparation is not yet available for clinical use, twice a day therapy may be the most reasonable option.9 A meta-analysis by Grozinsky-Glasberg and colleagues of 11 randomised trials (1216 patients) found no difference between combination and levothyroxine alone in the symptoms and measures it pooled, and concluded that levothyroxine monotherapy remains the treatment of choice for clinical hypothyroidism.10
Does any label or trial describe a liothyronine cycle?
The Cytomel label carries a boxed warning against use for weight loss, and says doses within daily requirements are ineffective for weight reduction in euthyroid patients.1 It warns that larger doses can be toxic, especially with sympathomimetic amines.1 It also says that bile acid sequestrants and ion exchange resins decrease thyroid hormone absorption, and to give Cytomel at least 4 hours before them or to monitor TSH levels.1
Is there a liquid or injection form to mix?
Tablets need no mixing, and the pack found no powder label for liothyronine. The injection label describes a ready aqueous solution in amber glass vials, with 10 mcg of liothyronine in each mL, not a powder to be mixed.6 It is for intravenous use only, not intramuscular or subcutaneous.6 The pack found no label that supports a U-100 syringe use.
How are liothyronine tablets stored?
The Cytomel and Liomny labels both say to store tablets between 15°C and 30°C (59°F and 86°F).12 The injection label says to store its vials between 2°C and 8°C.6 The pack found no stability data for a solution made from tablets.
Frequently asked questions
How fast does Cytomel act?
The label says onset occurs within a few hours and maximum response within 2 or 3 days.1
Is liothyronine on the WADA Prohibited List?
The pack's search of the WADA list found no passage naming thyroid hormones, so the page makes no statement either way.
References
- Pfizer Laboratories Div Pfizer Inc (DailyMed). These highlights do not include all the information needed to use CYTOMEL safely and effectively. See full prescribing information for CYTOMEL. CYTOMEL ® (liothyronine sodium) tablets, for oral use Initial U.S. Approval: 1956. 2026. dailymed.nlm.nih.gov
- DailyMed. These highlights do not include all the information needed to use LIOMNY safely and effectively. See full prescribing information for LIOMNY. LIOMNY TM (liothyronine sodium tablets, USP), for oral use Initial U.S. Approval: 1956. 2025. dailymed.nlm.nih.gov
- PubMed. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. 2003. pubmed.ncbi.nlm.nih.gov
- PubMed. Randomized double-blind placebo-controlled trial on levothyroxine and liothyronine combination therapy in totally thyroidectomized subjects: the LEVOLIO study. 2024. pubmed.ncbi.nlm.nih.gov
- PMC. A feasibility double-blind trial of levothyroxine vs. levothyroxine-liothyronine in postsurgical hypothyroidism. 2025. pmc.ncbi.nlm.nih.gov
- DailyMed. LIOTHYRONINE SODIUM INJECTION (T 3 ) Rx Only. 2026. dailymed.nlm.nih.gov
- PubMed. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. 2005. pubmed.ncbi.nlm.nih.gov
- PMC. Treatment of hypothyroidism with levothyroxine plus liothyronine: a randomized, double-blind, crossover study. 2016. pmc.ncbi.nlm.nih.gov
- European Thyroid Journal. Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document. pmc.ncbi.nlm.nih.gov
- PubMed. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. 2006. pubmed.ncbi.nlm.nih.gov